Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $28.17 USD
Change Today -0.15 / -0.53%
Volume 902.2K
EXAS On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 5:20 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for exact sciences corp (EXAS)

Exact Sciences Corporation be considered to have little financial risk as the capital structure does not rely on leverage.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Restated
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents35.813.312.958.1
Short-Term Investments57.694.8120.4224.6
TOTAL CASH AND SHORT TERM INVESTMENTS93.4108.1133.3282.8
Accounts Receivable------1.4
TOTAL RECEIVABLES------1.4
Inventory------4.0
Prepaid Expenses1.00.62.23.5
TOTAL CURRENT ASSETS94.4108.7135.5291.7
Gross Property Plant and Equipment3.45.214.226.4
Accumulated Depreciation-0.8-1.8-3.0-6.4
NET PROPERTY PLANT AND EQUIPMENT2.63.411.219.9
TOTAL ASSETS97.0112.1146.6311.6
    
LIABILITIES & EQUITY    
Accounts Payable0.83.70.92.6
Accrued Expenses3.13.35.014.0
Current Portion of Long-Term Debt/Capital Lease--0.30.40.4
Current Portion of Capital Lease Obligations--0.30.40.4
Other Current Liabilities, Total----1.20.6
Unearned Revenue, Current4.14.10.3--
TOTAL CURRENT LIABILITIES8.011.57.817.5
Long-Term Debt1.01.01.03.4
Capital Leases--0.70.4--
Unearned Revenue, Non-Current4.40.3----
Other Non-Current Liabilities0.00.12.21.7
TOTAL LIABILITIES13.513.511.322.6
Common Stock0.60.60.70.9
Additional Paid in Capital304.8372.1455.2709.0
Retained Earnings-221.8-274.2-320.8-420.8
Comprehensive Income and Other0.00.10.1-0.1
TOTAL COMMON EQUITY83.598.6135.3289.0
TOTAL EQUITY83.598.6135.3289.0
TOTAL LIABILITIES AND EQUITY97.0112.1146.6311.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAS:US $28.17 USD -0.15

EXAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Curis Inc $3.18 USD -0.10
Delcath Systems Inc $0.91 USD -0.0094
MELA Sciences Inc $1.16 USD +0.01
Navidea Biopharmaceuticals Inc $1.68 USD +0.06
ZIOPHARM Oncology Inc $11.22 USD -0.40
View Industry Companies
 

Industry Analysis

EXAS

Industry Average

Valuation EXAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 435.2x
Price/Book 9.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 393.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.